Live feed
Filing
SC 13D/A
SC 13D/A0000947871-23-000940·Damora Therapeutics, Inc.
Schedule 13D ownership disclosure
GALECTO INC
Security class unavailable · CUSIP: 36322Q107
Event date: 2023-09-12
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 2.8000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000947871-23-000940
- Form type
- SC 13D/A
- Filer
- Damora Therapeutics, Inc.
- CIK
- CIK 1800315
- Filed
- Sep 18, 2023
- Reporting period
- Sep 12, 2023
- Description
- Schedule 13D beneficial ownership